feedback

Course Director

Diana V. Do
Diana V. Do, MD

Vice Chair for Education
University of Nebraska Medical Center
Omaha, Nebraska

Accredited by

University of Florida College of Medicine

Activity Details

Credit Types:CME
Credit Amount:0.5 Credits
Release Date:2013-Dec-19
Estimated Time for Completion:30 minutes
Registration Required:No
Cost:Free

Activity Description & Educational Objectives

In this activity, an expert in retinal diseases discusses the most recent data on established and emerging therapies for the treatment of neovascular age-related macular degeneration, retinal vein occlusion, and diabetic macular edema.

Upon completion of this activity, participants should be better able to:

  • Apply recent efficacy and safety data on established and emerging therapies for the management of neovascular age-related macular degeneration
  • Employ the latest data on available and investigational therapies for the treatment of patients with macular edema secondary to retinal vein occlusion
  • Implement the most current clinical trial data on available and emerging therapies for the treatment of diabetic macular edema

Target Audience

This activity has been designed to meet the educational needs of retina specialists and ophthalmologists and other clinicians involved in the treatment and management of patients with retinal diseases.

Requirements for Successful Completion

In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.

Media: Internet
Release and Expiration Dates: December 19, 2013 - December 18, 2014
Time to Complete: 30 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, the University of Florida College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Interviewee

Diana V. Do, MD
Vice Chair for Education
Associate Professor of Ophthalmology
Director, Carl Camras Center for Innovative Clinical Trials
Director of Residency Program
Truhlsen Eye Institute
University of Nebraska Medical Center
Omaha, Nebraska

Diana V. Do, MD, has a financial interest/relationship or affiliation in the form of:
Grant/Research Support from Genentech, Inc. and Regeneron Pharmaceuticals, Inc.
Other Financial or Material Support from - Dr. Do's spouse serves as a consultant for Bausch & Lomb Incorporated and Santen Pharmaceutical Co., Ltd.

CME Reviewer

Anup Kubal, MD
Anup Kubal, MD
Clinical Assistant Professor
Department of Ophthalmology
University of Florida College of Medicine
Gainesville, Florida

Anup Kubal, MD, has no financial interests/relationships or affiliations in relation to this activity.

Medical Director

Christopher Washburn, PhD
PVI, PeerView Institute for Medical Education

Christopher Washburn, PhD, has no financial interests/relationships or affiliations in relation to this activity.

Sponsorship, Credit & Support

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education. The University of Florida College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The University of Florida College of Medicine designates this enduring material for a maximum of
0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity is jointly sponsored by the University of Florida College of Medicine and PVI, PeerView Institute for Medical Education.

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.